SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
-6.16%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$605M
AUM Growth
+$605M
(-8.3%)
Cap. Flow
-$4.4M
Cap. Flow
% of AUM
-0.73%
Top 10 Holdings %
Top 10 Hldgs %
49.83%
Holding
105
New
20
Increased
23
Reduced
13
Closed
26
Top Buys
| 1 |
Sanofi
SNY
|
$32.4M |
| 2 |
Novo Nordisk
NVO
|
$23.3M |
| 3 |
Sarepta Therapeutics
SRPT
|
$15.3M |
| 4 |
Gilead Sciences
GILD
|
$13M |
| 5 |
PTC Therapeutics
PTCT
|
$10.5M |
Top Sells
| 1 |
AstraZeneca
AZN
|
$31.8M |
| 2 |
GSK
GSK
|
$20M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$16.8M |
| 4 |
Verint Systems
VRNT
|
$12.8M |
| 5 |
BLUE
bluebird bio
BLUE
|
$9.54M |
Sector Composition
| 1 | Healthcare | 79.34% |
| 2 | Technology | 12.65% |
| 3 | Industrials | 2.41% |
| 4 | Consumer Discretionary | 1.28% |
| 5 | Communication Services | 0.85% |
